Biotech Stocks Healthcare Stocks Small Caps Stocks

Botanix (ASX:BOT) locks European applicator patent to 2039 as Sofdra eyes exit from US

Botanix Pharmaceuticals (ASX:BOT) has secured a European patent Intention to Grant on the Sofdra applicator, running to May 2039 and reshaping its ex-US options.

ByCharlie Youlden

16

Apr 2026

Biotech Stocks

Botanix Pharmaceuticals (ASX:BOT) lands Piramal API backup, targets 25% to 40% COGS cut

Botanix de-risks Sofdra supply chain with Piramal as second API source Botanix Pharmaceuticals (ASX:BOT) has taken a meaningful step forward in de-risking its supply chain, securing a second API supplier…

ByCharlie Youlden

28

Jul 2023

Uncategorized

ASX Life Sciences stocks: Here are 2 of the best!

ASX Life Sciences stocks discussed by Stuart Roberts as interest rates peak What are the Best ASX Stocks to invest in right now? Check our buy/sell tips on the top…

ByMarc Kennis

Botanix (ASX:BOT) locks European applicator patent to 2039 as Sofdra eyes exit from US

Botanix Pharmaceuticals (ASX:BOT) lands Piramal API backup, targets 25% to 40% COGS cut

ASX Life Sciences stocks: Here are 2 of the best!

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Botanix (ASX:BOT) locks European applicator patent to 2039 as Sofdra eyes exit from US

Botanix Pharmaceuticals (ASX:BOT) lands Piramal API backup, targets 25% to 40% COGS cut

ASX Life Sciences stocks: Here are 2 of the best!

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Add Your Heading Text Here